MTAP-DELETED PANCREATIC CANCER

Clinical trials for MTAP-DELETED PANCREATIC CANCER explained in plain language.

Never miss a new study

Get alerted when new MTAP-DELETED PANCREATIC CANCER trials appear

Sign up with your email to follow new studies for MTAP-DELETED PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug trial targets aggressive pancreatic Cancer's genetic weakness

Disease control Terminated

This study is testing if adding an experimental drug called BMS-986504 to standard chemotherapy helps control pancreatic cancer in people whose tumors have a specific genetic change called an MTAP deletion. It aims to see if the combination is safe and can slow cancer growth or i…

Matched conditions: MTAP-DELETED PANCREATIC CANCER

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

MTAP-DELETED PANCREATIC CANCER

Get alerted when new MTAP-DELETED PANCREATIC CANCER trials appear

New drug trial targets aggressive pancreatic Cancer's genetic weakness